{"id":97837,"date":"2020-11-30T11:05:45","date_gmt":"2020-11-30T05:05:45","guid":{"rendered":"https:\/\/toptrendingnews.co\/moderna-to-seek-quick-approval-of-coronavirus-vaccine-in-us-europe\/"},"modified":"2020-11-30T23:25:33","modified_gmt":"2020-11-30T17:25:33","slug":"moderna-to-seek-quick-approval-of-coronavirus-vaccine-in-us-europe","status":"publish","type":"post","link":"https:\/\/toptrendingnews.co\/moderna-to-seek-quick-approval-of-coronavirus-vaccine-in-us-europe\/","title":{"rendered":"Moderna to Seek Quick Approval of Coronavirus Vaccine in US, Europe"},"content":{"rendered":"
Drugmaker Moderna said Monday it is seeking emergency authorization in the United States and Europe to distribute its coronavirus vaccine after tests showed it is 94% effective.<\/p>\n
The U.S. biotechnology company\u2019s request could mean that health workers will be able to inoculate patients against the virus as soon as mid-December with either of two coronavirus preventatives \u2014 Moderna\u2019s or another equally successful test drug produced by the corporate tandem of Pfizer-BioNTech \u2014 if the companies win approval from drug regulators.<\/p>\n
Moderna said it conducted a 30,000-person clinical trial, and its results were on a par with the best pediatric vaccines.<\/p>\n
The drugmaker said that of the 196 volunteers who contracted COVID-19, 185 had received a placebo versus 11 who received the vaccine. Moderna reported 30 severe cases \u2014 all in the placebo group \u2014 including one COVID-19-related death. <\/p>\n
The Moderna and Pfizer requests for emergency use of their vaccines come as the number of coronavirus cases is surging in the U.S., where tens of thousands of new cases are being recorded daily.<\/p>\n
Health officials say they are especially worried about an even further spread of the virus because millions of people ignored warnings against traveling for last week\u2019s Thanksgiving holiday and could travel again over the upcoming Christmas and New Year\u2019s holiday weekends.<\/p>\n